Baroness Sayeeda Warsi is to take on a new challenge in 2021 when she joins the line-up of Stand Up and Deliver, a new series by Channel 4 in aid of Stand Up To Cancer.
Baroness Warsi has been a member of the House of Lords since 2007 and has served in government on the cabinet of former Prime Minister David Cameron.
Baroness Warsi resigned from the Government in 2014 citing concerns that she was no longer able to support the Cameron Government’s policy on the escalation of violence in the Israel–Gaza conflict, describing the Government’s position as “morally indefensible
Her new challenge will see the Baroness join Reverend Richard Coles, Singer Shaun Ryder, Love Island’s Curtis Pritchard and former Coronation Street actress Katie McGlynn in an attempt to master the art of comedy.
Baroness Warsi will be mentored in the two-part series by Nick Helm as she aims to perfect a routine before performing a special stand-up performance, hoping to be crowned Stand Up and Deliver Champion
Becky Cadman, Commissioning Editor for Factual Entertainment at Channel 4 said, “This joyous Fact Ent series is both a masterclass in comedy, and a dramatic test of character. A Reverend, an actress, a politician, a reality star, and a musical legend already sounds like the start of a joke and watching them learn the craft of stand-up from five of the best in the business is brilliantly entertaining.”
The programme will be made by Lime Pictures under Sarah Tyekiff, Head of Unscripted who said “We couldn’t be happier to be making this new format for Channel 4 and Stand Up To Cancer. Five famous faces are about to be thrust into the often harsh and unforgiving world of stand up. It’s going to be comedy gold. We cannot wait to see which of our celebrities will stand up to the challenge.”
Launched in the UK in 2012, Stand Up To Cancer is a joint national fundraising initiative from Cancer Research UK and Channel 4 that brings the UK together to speed up progress in life-saving cancer research. To date, Stand Up To Cancer has raised more than £62 million, funding 55 clinical trials and projects, involving over 11,000 patients across the country.